UNITED STATES OF AMERICA
 

BEFORE THE FEDERAL TRADE COMMISSION
 

In the Matter of ) Docket No. 9327

) PUBLIC 

) 

) 

Polypore International, Inc. 

a corporation 

) 

) 

) 

) 

) 

EXIDE TECHNOLOGIES' MOTION FOR IN CAMERA TREATMENT OF 

CERTAIN MATERIL DESIGNATED AS TRIL EXHIBITS 

Nonparty Exide Technologies moves, pursuant to Federal Trade Commission 

("FTC") Rule of Practice 3.45(b), 16 C.F.R. § 3.45(b), for an order directing in camera 

treatment of certain documents that Complaint Counsel and Respondent have designated 

as trial exhibits. The Declaration of Pradeep Menon (Attachment A), identifies the 

specific documents for which in camera treatment is requested, and also explains why 

public disclosure of that material would cause serious commercial and competitive harm 

to Exide. 

BACKGROUND 

Exide Technologies is one of the world's largest producers of batteries. For that 

reason, it is also one of the largest purchasers of battery separators. In the course of its 

investigation of Respondent's acquisition of Microporous Products, the FTC issued a 

comprehensive subpoena to Exide, which required the production of a large volume of 

highly confidential documents and information. Mter the FTC filed its complaint in this 

matter, Polypore issued its own subpoena, which was even broader than the FTC's. 
On March 27, 2009, Exide received a letter from Complaint Counsel providing 

notice that 94 Exide documents would be introduced into evidence in this proceeding. 

Attachment B. On the same date, Polypore notified Exide that it intended to introduce 

Exide documents and/or testimony into evidence, but failed to identify which documents 

or testimony it intended to use. Attachment C. On March 31, 2009, Polypore provided a 

list of 62 documents and 168 excerpts of deposition testimony it intended to use. 

Attachment D. In addition, the entire 300-page transcript of Mr. Gillespie's 

investigational hearing was included on Polypore's list; Polypore subsequently informed 

Exide that it did not intend to use Mr. Gillespie's investigational hearing transcript in its 

case in chief, but designated the transcript for possible use in cross-examination. 

Included within the large volume of documents designated as trial exhibits are 

certain documents Exide considers highly confidentiaL. Exide submits this motion to 

request in camera treatment for this materiaL. 

ARGUMENT 

Exide seeks in camera treatment of certain documents because public disclosure 

of that material would cause serious commercial and competitive harm to the company. 

As explained in the Menon Declaration, three categories of documents are at issue. First, 

many of the documents reveal confidential information about ongoing contract 

negotiations between Exide and potential suppliers of separators. Second, many 

documents reveal detailed information about prices, costs, and volumes, and specific 

terms of confidential contracts. Third, some of the documents describe Exide' s strategic 

plans. 

2
 
The company treats all of this information as highly confidentiaL. It is distributed 

within the company only to those who have a specific need for it, and those individuals 

typically are bound by confidentiality agreements that prohibit them from disclosing 

confidential information if they leave the company. The information is not disclosed to 

others outside the company. In particular, it is not disclosed to suppliers or competitors. 

The request of a nonparty for in camera treatment "deserve( s) special solicitude" 

because "as a policy matter, extensions of confidential or in camera treatment in 

appropriate cases involving third party bystanders encourages cooperation with future 

adjudicative discovery requests." In re Kaiser Aluminum & Chemical Corp., 103 F.T.c. 

500,500 (1984). But the documents discussed below deserve in camera treatment under 

any standard. 

Confidential Information About Ongoing Contract Negotiations 

Exide currently purchases polyethylene separators from Daramic, pursuant to a 

long-term contract that expires at the end of 2009. Because of the substantial lead time
 

required to qualify a new supplier, Exide issued an RFP in 2007, seeking offers to supply 

separators to Exide beginning in 2010. (Before issuing the RFP, Exide had discussions 

with Daramic about the terms of a potential extension of their existing relationship.) 

Since that time, Exide has had many discussions with potential suppliers, but has not yet 

completed the negotiation of a new contract. 

Exide seeks in camera treatment for documents that reveal information about 

these ongoing negotiations. These documents include information about the offers that 

Exide has received from potential suppliers (including price, volume, and other terms), 

Exide's internal evaluations of those offers, and Exide's negotiating strategies and
 

3
 
objectives. Exide would be severely harmed in these ongoing negotiations if Daramic 

obtained detailed information about a competitor's offers to Exide, or if a competitor
 

obtained detailed information about Daramic's offers. Similarly, Exide would be 

prejudiced if potential suppliers obtained detailed information about Exide's negotiating 

strategies, its objectives, and the alternatives available to Exide. 

Exide requests that these documents be held in camera for a period of three years. 

Exide wil need to arrange for the purchase of separators from some supplier(s) beginning 

in 2010, when its current contract expires. But it is possible that Exide will choose only 

an interim supply arrangement at that time, in the expectation that this litigation will 

produce a competitive market in which Exide wil obtain more favorable terms than are 

available in today's uncompetitive market. Disclosure of information about current 

negotiations could harm Exide in those efforts. A confidentiality period of three years 

wil permit the conclusion of this litigation, the implementation of a remedy (presumably, 

a divestiture), and orderly contract negotiations for a new supply arrangements, untainted 

by exposure of detailed information about the current negotiations. 

Detailed Information About Prices, Costs, and Contract Terms 

Exide also requests in camera treatment of documents that reveal specific and 

detailed information about costs, prices, volumes, and contract terms. Where practicable, 

we have requested only the redaction of specific numbers and terms, so as to permit the 

reader of a redacted version to understand the meaning and significance of the document. 

As the Menon Declaration explains (~~ 12-13), some of this information reveals specific 

information about the company's current contract with Daramic. Release of this
 

information could adversely affect the company's negotiating position with potential new 

4
 
suppliers. The information would also permit Exide's competitors to gain a detailed 

understanding of 
 Exide's business, which they could exploit to Exide's detriment. 

The Commission provided in camera treatment for information of this kind in E. I 

DuPont de Nemours & Co., 97 F.T.C. 116 (1991). The Commission protected data 

concerning "trends of profits, earnings, unit costs and sales volume" that "might enable 

competitors to extrapolate an accurate model of (the company's) current business." 97 

F.T.C. at 116. It also protected "certain comparisons of costs of production by plant" and 

price lists that contained "indexed averages of actual discount prices which are secret and 

which would assist its competitors if released." Ibid. 

Exide requests in camera treatment for these documents for a period of one year. 

Strategic Planning Documents 

Three of the documents are strategic planning documents that disclose sales 

opportunities, product plans, strategies for dealing with specific customers, price and 

volume information, evaluations of specific suppliers, potential business partners and 

opportunities, and more. For obvious reasons, disclosure of this information to Exide's 

suppliers, competitors, or customers would place the company at a competitive 

disadvantage and cause commercial or competitive harm. Menon Declaration ~~ 18-19. 

Exide requests in camera treatment for these documents for a period of two years, to 

permit the company to execute and benefit from its plans before they are disclosed to 

competitors and others. 

5
 
CONCLUSION
 

For the foregoing reasons, Exide Technologies' Motion For In Camera Treatment 

Of Certain Material Designated As Trial Exhibits should be granted. 

Dated: April 9, 2009 Respectfully submitted, 

~~#~ 

Donald J. Russell 

ROBBINS, RUSSELL, ENGLERT, ORSECK, 

UNTEREINER & SAUBER LLP 

1801 K Street, N.W., Suite 411L 

Washington, D.C. 20006 

Telephone: (202) 775-4500
 

Facsimile: (202) 775-4510 

drussell (crob binsru ssell. com 

Counsel for Exide Technologies 

6 
UNITED STATES OF AMERICA
 

BEFORE THE FEDERAL TRADE COMMISSION
 

In the Matter of	 Docket No. 9327 ) 

) 

) 

) 

) 

Polypore International, Inc. ) 

a corporation	 ) 

) 

) 

PROPOSED ORDER 

Upon the motion of non-party Exide Technologies, and for good cause shown, it 

is hereby ORDERED: 

The following confidential documents, designated as proposed trial exhibits, shall 

be placed in camera, for the period of time indicated below: 

Exhibit No. Beginning Bates Redactions Duration 

Number Requested 

PX1007 EX005853 EX005856 1 year 

PX1014 EXOO0118 EXOOO118 1 year 

PXI026 EXOO0984 1 year 

PXI027 EX002384 3 years 

PXI028 EXOO1134 3 years 

PX1029 EX003241 3 years 

PX1030 EX002452 3 years 

PXI033 EX005442 3 years 

PXI034 EX002688 3 years 

PXI035 EX005445 3 years 

PXI036 EX005497 3 years 

PX1037 EX003659 3 years 

PXI039 EX005489 3 years 

PX1040 EX004795 3 years 

PXI046 EXOO0259 3 years 

PX1049 EX002390 Passim 1 year 

PXI050 EX011938 3 years 

PX1053 EX001057 1 year 

PX1054 EX008649 EX008649 1 year 
Exhibit No.
 

PXI063 

PXL064 

PXL069 

PXI076 

PXI077 

PX1078 

PXlO82 

PXlO97 

PX1900 

PX1901 

PX1902 

RXOO1 44
 

RX00301 

RX00303 

RX00309 

RX00313 

RX003 17 

RXOOO 17 

RX00264 

RX00265 

RX00267 

RX00269 

RX00360 

RXOO012 

RX00145 

ORDERED: 

Date: 

Beginning Bates
 

Number
 

EX011811
 

EX012123
 

EX008239
 

EX009960
 

EX002386
 

EX009961
 

EX010838
 

EX021597
 

ETI 0005322
 

ETI 0006605
 

ETI 0000009
 

EX004554; 4405
 

ETI 0059099
 

ETI 001 9983
 

ETI 0040844
 

ETI 0073695
 

ETI 0006548
 

ETIHC 0001712
 

ETIHC 000001 7
 

ETIHC 0000042
 

ETIHC 0000050
 

ETIHC 0000070
 

ETIHC 0000004
 

EXOO0269
 

EX003662
 

Redactions Duration 

Requested 

3 veal'S 

1 year 

1 year 

1 year 

3 years 

1 year 

3 years 

EX021599-600 1 year 

ETI 0005322 1 year 

1 year 

3 years 

1 year 

2 years 

2 years 

1 year 

2 veal'S 

3 years 

Passim 1 year 

1 year 

1 year 

1 year 

3 years 

1 year 

3 years 

3 years 

D. Michael Chappell 

Administrative Law Judge 

2
 
CERTIFICATE OF SERVICE 

I hereby certify that on April 9, 2009, I caused to be filed via hand delivery and 

electronic mail delivery an original and two copies of 
 the foregoing Exide Technologies'

Motion For In Camera Treatment Of Certain Material Designated As Trial Exhibits, and 

that the electronic copy is a true and correct copy of the paper original and that a paper 

copy with an original signature is being filed with: 

Donald S. Clark, Secretary
 

Office of the Secretary
 

Federal Trade Commission
 

600 Pennsylvania Avenue, N.W., Rm H-135
 

Washington, D.C. 20580
 

secrctary(cftc. gov 

I hereby certify that on April 9, 2009, I caused to be served one copy via 

electronic mail delivery and two copies via hand delivery of the foregoing Exide 

Technologies' Motion For In Camera Treatment Of Certain Material Designated As Trial 

Exhibits upon: 

The Honorable D. Michael Chappell
 

Administrative Law Judge
 

Federal Trade Commission
 

600 Pennsylvania Avenue, N.W.
 

Washington, D.C. 20580
 

oalj (aftc. gov 

I hereby certify that on April 9, 2009, I caused to be served by first class mail 

delivery and electronic mail delivery a copy of 
 the foregoing Exide Technologies'

Motion For In Camera Treatment Of Certain Material Designated As Trial Exhibits upon: 

Wiliam L. Rikard, Jr. J. Robert Robertson 

Eric D. Welsh Steven Dahm 

Three Wachovia Center Federal Trade Commission 

401 South Tryon Street, Suite 600 Pennsylvania Avenue, N.W. 

3000 Washington, D.C. 20580 

Charlotte, N.C. 28202 rrobertson(ü)ftc.gov 

willi amrikard(cparkerpoe. com sdahm(cftc.gov 

ericwelsh0)parkerpoe.com 
p 

If 
DECLARTION OF PRAEEP MENON
 

1. I, Pradeep Menon, submit this declaration in support of Exide Technologies'
 

Motion For In Camera Treatment Of Certain Material Designated As Trial Exhibits, 

submitted in In the Matter of Polypore International, Inc., FTC Docket No. 9327. I have 

reviewed the documents listed in the Appendix to this declaration. For the reasons 

explained below, I have concluded that Exide wil suffer serious commercial or
 

competitive harm if this material is publicly released. 

2. I am currently the Vice President of Commodities and Strategic Supplier
 

Development at Exide. In that capacity, I am responsible for developing and managing 

supply relationships with producers of critical commodities and components used to 

manufacture batteries. I have had substantial involvement in Exide's procurement of 

polyethylene separators and in the company's efforts to negotiate new separator supply 

arrangements that will take effect when the company's contract with Daramic expires, at 

the end of2009. 

3. Exide has been notified by the FTC and by Polyp ore that a large number of Exide 

documents may be introduced into evidence durng the trial of this case. Some of those 

documents are highly confidential; the public disclosure of those documents would 

seriously harm Exide's commercial and competitive interests. For that reason, Exide 

requests that this material be given in camera treatment until such time as disclosure wil 

not cause this har. 

4. Exide requests in camera treatment for material that falls into three categories. 

First, many of the documents relate to Exide's ongoing negotiations for new supply 

arrangements for separators. Second, Exide also requests in camera treatment for 

material that reveals specific information about prices, costs, volumes, and contract 

terms. Third, Exide requests in camera treatment of strategic plans. 
5. All of 
 this material is treated by the company as highly confidentiaL. The material 

is distributed within the company only to those who have a specific need for the materiaL. 

Those individuals are typically bound by confidentiality agreements that would prohibit 

them from disclosing the information if they left the company. The material is not 

disclosed to others outside of the company and, in paricular, is not disclosed to Exide's 

competitors or suppliers. Such disclosure would be harmful to Exide for the reasons 

explained below. 

On2:oin2: Contract N e2:otiations 

6. Documents relating to Exide's ongoing negotiations for new separator supply 

arangements constitutes much of the material for which in camera treatment is 

necessary. Exide currently purchases separators pursuant to a long-term agreement with 

Daramic, which ends in December 2009. Negotiating a new supply arrangement requires 

an extended period of time. A new supplier must complete a lengthy testing and 

qualification process; some potential suppliers must also invest in new production 

facilities and equipment. Because of the long lead time, Exide discussed the possibility 

of a contract extension with Daramic in late 2006. When those discussions failed to yield 

agreement on a contract extension, Exide began preparing an elaborate RFP, which was 

issued in the sumer of 2007. After receiving proposals from separator manufacturers,
 

Exide embarked on a lengthy process of evaluation, product testing, and negotiation. 

7. In February 2008, Exide intended and expected to enter into a supply agreement
 

with Microporous Products, L.P. Daramic's acquisition eliminated Microporous as an 

independent competitor in the market, and caused a major setback in Exide's efforts to 

negotiate new supply arangements. Exide has not yet been able to negotiate 

arrangements for separator supply after the expiration of the Daramic contract. The 

negotiations for new supply arrangements which began in late 2006 are ongoing today. 

8. The documents identified in the Appendix by the designation "Contract 

Negotiations" relate directly to those ongoing negotiations. That material includes 

2
 
contract proposals, or discussions about such proposals, from potential suppliers. It also 

includes Exide's communications with potential suppliers, Exide's assessments of its 

contracting options, and Exide's strategies for achieving the best possible contract. 

9. All of this material is regarded as highly confidential by Exide. If one potential
 

supplier were to learn details of the proposals submitted by another potential supplier, 

that information could dramatically alter the terms of the bidding, to Exide's detriment. 

Similarly, if a potential supplier were to learn details of Exide's negotiating strategies, 

Exide's negotiating position would be severely compromised. Such harm could result 

from the disclosure of any of the terms that are the subj ect of the negotiations, including 

but not limited to price, volume, and payment terms. 

10. It is not yet clear when Exide wil complete negotiations for new supply
 

arrangements. One possible outcome of this legal proceeding wil be the creation of a 

new competitor that wil restore the competition lost as a result of 
 Daramic's acquisition 

of Microporous. Because of that possibility, Exide may choose to negotiate an interim 

supply arrangement beginning in January 2010, in the hope of negotiating a long term 

arrangement at a later time, when this litigation has restored competition to the market. If 

Exide adopts this approach, the need to prevent disclosure of contract negotiation 

material will continue through the signing of 
 those "permanent" supply agreements. For 

this reason, I believe that all material related to the current negotiations should continue 

to receive in camera treatment for a period of three years, and that any shorter period
 

would risk substantial competitive and commercial harm to Exide. 

Detailed Price. Cost. and Volume Information 

11. Exide also requests in camera treatment of documents that reveal detailed 

information about prices, costs, and volumes, and information about specific terms in 

contracts that are confidentiaL. This material is identified in the Appendix by the 

designation "P/CN." I believe that public release of this information would cause 

serious commercial and competitive harm to Exide. 

3 
12. Some of this information concerns specific pnce Increases proposed or 

implemented under Exide's current contract with Daramic, or specific nonpublic terms of 

that contract. This information, like the information concerning Exide's current
 

negotiations, could adversely affect Exide's negotiating position. The information will 

permit Daramic's competitors to more accurately gauge the current terms on which Exide 

purchases separators. That knowledge would likely affect the terms that would be 

offered by those competitors for a new supply arangement. 

13. Detailed information concernIng pnces, costs, and volume would also be
 

extremely valuable to Exide's competitors. They could use such information to develop a 

detailed understanding of Exide's business, identifying Exide's strengths and 

weaknesses, and potential vulnerability to competitive inroads. 

14. In many cases, the harm to Exide from the release of documents containing this 

material can be avoided by redacting specific numbers, without redacting the text 

surrounding the numbers. The Appendix identifies those documents for which redaction 

is appropriate. (If a document is not so identified, in camera treatment of the entire
 

document is needed.) The information to be redacted is indicated by highlighting in the 

attached documents. Exide has attempted to limit its proposed redactions so that they 

will not conceal the meaning and significance of the document, but wil merely prevent 

unnecessary disclosure of 
 highly sensitive information that has little bearing on the issues 

in this case. 

15. One document, at Tab 29 (PX1901) (ETI_0006605), contains brief references to 

separators, but extensive and detailed information about costs for a wide array of other 

commodities and components. It would be especially unfortunate if this highly 

confidential information were disclosed, because it is entirely unelated to competition in 

the production and sale of separators. 

4
 
16 The risk of harm to Exide from the disclosure of price, cost, and volume 

information wil diminish more rapidly than the risk of harm from disclosure of contract 

negotiation information. Protection from disclosure of the former for a period of one 

year wil prevent the most serious harm to Exide.
 

Strate2:ic Plannin2: Documents 

17. Finally, Exide requests information for three strategic planing documents. The
 

documents are identified in the Appendix by the designation "Strategic Plan." Disclosure 

of these documents to Exide's separator suppliers and/or Exide's competitors would 

cause serious commercial and competitive harm. 

18. These documents reveal, among other things, sales opportnities, product plans, 

strategies for dealing with specific customers, detailed price and volume information 

(both historical and projected), evaluations of specific suppliers, and potential business 

partners and opportunities. Exide's competitors and suppliers could more effectively 

counter Exide's competitive and procurement initiatives if 
 they had access to these highly 

confidential plans. 

19. The plans identify certain strategies to be implemented over a period of years. To 

the best of my knowledge, Exide's competitors and suppliers do not yet know about, or 

have only vague and limited knowledge about, these strategies and plans. In camera 

treatment for a period of two years would protect Exide's ability to execute and benefit 

from these plans. Disclosure prior to that time would risk serious competitive and
 

commercial harm. 

I declare under penalty of perjury that the foregoing is true and correct. 

lL- 4-/+/ ~f

Pradeep Menon Date, '

5
 
¡l6
 
UNITD STATES OF AMERICA
 

FEDERAL TRADE COMMISSION 

WASHINGTON, D.C. 20580 

Bureau of Coinpeiiiion 

Direct Dial 

(202) 326-2192 

March 25, 2009
 

via Express Mail 

Donald J. Russell, Esq. 

Robbins, Russell, Engleit, Orseck, Untereiner & Sauber LLP 

1801 K Street N.W., Suite 411L
 

Washington, D.C. 20006
 

Re: Polypore Inte11atiolial, Inc. 

FTC Docket No. 9327 

Dear Mr. Russell: 

We are contacting you to provide you and your client foimal notice, pursuant to 16 

C.F.R. § 3.45(b), that Complaint Counsel has placed documents from Exide on its exhibit list 

and intends to offer these documents into evidence in the administrative tiial in this matter. The 

administrative tiial is scheduled to begin on May 12,2009. All exhibits admitted into evidence 

become pait of the public record unless in camera status is granted by the Administrative Law 

Judge, D. Michael Chappell. Enclosed with this letter is a list identifying the documents from 

Exide that are included on Complaint Counsel's exhibit list and a CD containing a copy of those 

documents. 

For documents that include sensitive or confidential information that you do not want on 

the public record, you must fie a motion addressed to Judge Chappell seeking in camera status 

or other confidentiality protections for the information pursuant to16 C.F.R. § 4.1O(g). Judge 

Chappell may order that materials, whether admitted or rejected as evidence, be placed in 

camera only after finding that their public disclosure wil 
 likely result in a clearly defined,
 

serious injury to the person, partnership or corporation requesting in camera treatment.
 

Motions for in camera treatment for evidence to be introduced at trial must meet the 

stiiet standards set forth in 16 C.F.R. § 3.45 and explained in In re Dura Lube Corp., 1999 FfC 

LEXIS 255 (Dec. 23, 1999); In re Hoechst Marion Roussel, Inc., 2000 FTC LEXIS 157 (Nov. 

22,2000) and 2000 FfC LEXIS 138 (Sept. 19,2000); In re Basic Research, Inc., 2006 FTC 

LEXIS 14 (Jan. 25,2006). Motions also must be sUPPOlted by a declaration or affidavit by a 

person qualified to explain the confidential nature of the documents. In re North Texas Specialty 

Physicians, 2004 FfC LEXIS 66 (April 23, 2004). Each pary or non-paity that files a motion 
for in caiiera treatment shall provide one copy of the documents for which Í1icamc;ra treatment 

is sought to Judge Chapell. Finally, examples of 
 motions requesting Ùi camera treatment can be 

found by searching the FfC website (i.e., www.ftc.gov). 

Please be aware that under the Clll'ent Scheduling Order, the deadline for filing motions 

seeking Í1/ camerä status is April 9, 2009. By that date, an oiiginaland two copies of yoiir 

motion should be fied with the Offce 
 of the Secretary, Room H135 at 600 Pennsylvania 

Avenue, N.W., Washington D.C. 20580. Also, serve copies 
 of yom motion as follows: 

(1) send two copies by first class mail and e-mail a copy to Honorable D. Michael Chappell, 

Administrative Law Judge, Federal Trade Commission, 600 Pennsylvania Avenue, NW, H-106, 

Washington, DC 20580 (oali Wftc.gov); (2) Send copies by fitst class mail and e-mail a copy to 

counsel for Respondent Polypore International, Inc: Wiliam L. Rikard,Jr. and Eric D. Welsh at 

Parker, Poe, Adams & Bernstein, LLP, Three Wachovia Center, 401 South Tryon Street, Suite 

3000, Charlotte, North Carolina 28202; williamrikard(!parkerpoe.coni and 

ericwelshWparkerpoe.com : and (3) Send copies by first class mail and e-mail a copy to 

Complaint Counsel: 1. Robert Robertson and Steven A, Dahm at Federal Trade Commission, 600 

Pennsylvania Ave., NW, Washington, DC 20580 (rrobertson(âftc.gov and sdalim(!ttc.gov). 

If you have any questions, please call me at 202-326-2192. 

Regards, 

41. "7'.'/7 .../...... ­ 'i/ ~-----"

Steven A. Dahm 

Attorney 
--- COMPLAINT COUNSEL'S FINAL PROPOSED EXHIBIT LIST 

EXHIBIT 

NO. EXHIBIT TITLE 

Declaration of Douglas Gilespie 

PXOO05 (Exide) 

LeUer to Roe from Gilespie re: 

PX1000 --~~ Proposed Price Adjustment 

Leiter to Roe from Gilespie re: 

Response to your proposal dated 

PX1003 September 19th 

Emailto Gilespie from Bregman re: 

PX1006 Audit 

Email to Sherrick from Hatcher re: 

PX1007 Proposed Price increase w/Atlach. 

Email to Gilespie from Smith re: 

PX1009 Special Industrial Separators 

Email to Miler from Berger re:-­

PX1010 Technical Conf. Call Agenda 

Email to Perez from McDonald re: 

Global Separator Conference in 

PX1012	 Paris h_._'~~___ 1----_.- Emailto Smith from Berger re: 

PX1013	 Err~~~!!~~J~~_~QQ?,_~lAt!ach.___ _ 

Email to Perez from Berge-i-re:' 

PX1014	 Exìde Pricing 

Email to Perez from Berger re: 

Global Separator Conference in 

PX1016 Paris w/Attach. 

Emailto Perez from Berger re: 

PX1017	 Rubber w/Attach. 

Emailto Perez from Berger re: 

Global Separator Conference in 

PX1018	 Paris w/Attach. 

Email to Perez from Gilchrist re: 

PX1020	 Rubber 

Email to Menon from Gilchrist re: 

PX1021	 Exíde MOU Extension w/Attach. 

Email to Perez from Gilchrist ra: 

PX1022	 Rubber 

Presentation: Battery Separator 

. Capabilties Microporous Products 

L.P. - Paris Separator Supplier 

PX1023	 Conference 

Email to Wimberly, Berger, et al. 

from Miler re: Amerace Material 

PX1024 Characteristic Results 

Email to Wimberly from Miler re: 

PX1025 Amerace Bristol Trials 

Emailto Gilespie from Roe ra: 

PX1026 Contract Proposal 

DATE 

8/9/2008 

6/27/2005 

9/22/2005 

7/27/2005 

1/25/2007 

--_.
 3/14/2008

4/16/2007 

1/2/2008 

1/2/2008 -._._-_. ---_.. ---- u_u_.________. 

12/26/2007 

1/2/2008 

12/19/2007 

1/2/2008 

12/22/2007 

2/18/2008 

12/20/2007 

1/11/2008 

1/8/2008 

1/25/2008 

BEG DOC 

FTC-ETI-000648 

EXOO0258 

EX005730 

EXOO0953 

EX005853 

EX006106 

EXOO5380 

EXOOO110 

EXOO0117 

EXOOO118 - .___0- _
 

EXOO0120
 

EXOOO127
 

EXOOO129 

EXOO0137 

EXOO0139 

EXOO0140 

EXOO0144 

EX005536 

ENDDOC 

FTC-ETI-000651
 

EXOO0263
 

EXOO5731
 

EXOO0954
 _ __.______.._~.~_.A~____d__
 

EX005856 

EX006109 

EX005382 

EXOO0116
 

EXOO0117
 -


EXOO0118
 

EXOO0126
 

EXOO0128
 

EXOO0135
 

EXOO0138
 

EXOO0139
 

EXOO0143
 

EXOO0257 

EX005536
 

EXOO5574 EX005576
 ...- .--_...... ".---._"-.----- -------- ._____________._____.________ _"'H." 

2/3/2007 EXOO0984 EXOO0985 

CONFIDENTIAL - FTC DOCKET NO. 9327
 
-- ------

--

COMPLAINT COUNSEL'S FINAL PROPOSED EXHIBIT LIST
 

EXHIBIT 

EXHIBIT TITLE NO. 

Emailto O'Leary from Menon re: 

PX1027 Daramic w/Atlach. 

Emailto Gilespie from Roe re: RFP 

PX1028 Response wlAtlach. 

Email to Menon from Roe ore: Global 

PX1029 Supply Quote -

Emailto Gilespie from Roe fe: 

PX1030 DaramiclExide Analysis w/Atlach. 

Email to Menon from Gilchrist re: 

PX1031 Arbitration with Daramic 

Letter to Gilchrist from Menon fe: 

PX1032	 Extending non-binding MOU 

Email to Menon from Simon fe: 

Summary of our meeting with Entek 

PX1033 on Feb 28th w/Attach.
 

Email to Menon from Smith re:
 

~_1034 Separator RFP
 

Emailto Smith from Lembree re:
 

Amer-Sit special separator proposal 

PX1035	 wlAltach. -,~." 

EmaiftoGJITespie from Smithre:V2 

Global Separator RFP Summary 9­

PX1036	 05-07 

Email to Menon from Smith ra: 

PX1037	 Separator Benefis w/AUach. 

Email to Menon from Gilespie re: 

PX1038	 Reasons for Option 2
 

Email to Menon from Smith re: V2
 

Global Separator RFP Summary
 

PX1039 w/Attach. 

Emailto Menon from Smith re: 

PX1040 Separator Sourcing w/Attach. 

Email to Gilespie from Menon re: 

Updated: Global Separator Strategy
 

PX1041	 Team Meeting w/Attach. 

Email to Wilson from Miller re: 

Global Separators Minutes ­

PX1043	 04/12107 w/Attach. 

Emallto Menon from Smith re: 

Global Separator RFQ Technical 

PX1044 Specification 

Emailto Gilespie, Menon et al. 

PX1045 from Smith ra: Tímelíne w/Attach. 

LeUer to Roe from Gillespíe ra: 

PX1046	 Contract Extension Proposal 

-

-

DATE BEGDOC ENDDOC
 

6/5/2007 EX002384 EX002389
 

611312007 EX001134 EX001193
 _._~ 

8/29/2007 EX003241 EX003244 

11/19/2007 EX002452 EX002453 

9/24/2007 EX002380 EX002380 ~-_.~ -	 -­

2/1412008 EX002503 EX002503 ,,'~ 

311/2007 -	 EXOO5442 EX005444 

6/18/2007 EX002688 EX002704 

--- . 7/24/2007 EX005445 EX005470 ._- ... .....'_._.._----------._- ....... .__._.,~__.w.~__ 

9/6/2007 EXOO5497 EX005506 -

8/29/2007 EX003659 EX003660 

8/2912007 EX003432 EX003432 

8/29/2007 EX005489 EXOO5496 

712412007 EX004795 EX004797 

3/1/2007	 EXOO3428 EX003429 

4118/2007 EX003226 EX003240 

4/30'2007 EX002528 EX002664 

9/6/2007	 EXOO5383 EX005385 

12/1/2006 EXOOO259 EXOOO260 

CONFIDENTIAL - FTC DOCKET NO. 9327
 
---------

COMPLAINT COUNSEl'S FINAL PROPOSED EXHIBIT LIST 

EXHIBIT 

NO. 

PX1047 

PX1048
 

PX1049
 

PX1050
 

PX1051
 

PX1052 

PX1053
 

PX1054
 -'-'--.--_."_.'_.._.­

PX1055 -

PX1056 

PX1057 

PX1059 

PX1060 

PX1061 

PX1062 

PX1063 

PX1064 

PX1065 

PX1066 

PX1067 

PX1068 

EXHIBIT TITLE 

letter to Roe from Menon re: Exide 

Technologies RFP for Global 

Separator Purc~ases w/Attach. 

letter to Gilespie from Roe re: 

Declaration of Force Majeure for 

Daramic LLC and its subsidiaries 

Email to Menon from Gilespie re: 

Daramic Contracts w/Attach. 

Email to Bregman from Bregman re:
 

Daramic note to fie
 

Email to Roe from Perez re:
 

Amerace Product; 

Email to Perez from McDonald re: 

Preparation for Feb 27 meeting 

Email to Gilespie from Roe re: 

Freight calculation from China/HP 

200 

Email to Perez from Roe ra: Follow 

Up 

Email to Perez fromMëOonaicirë:--­

Quote 

Email to Menon from Gilchrist re:
 

Arbitration with Daramic
 -

Amerace Agenda 

Email to Menon from Smith ra: 

Meeting Follow-up
 

Email to Smith from Berger re:
 

Discussions
 

Email to Perez from Wilhjelm re:
 

Outstanding AIR
 

Email to Perez from Smith fe:
 

Amerace/Daramic
 

Email to Ulsh from Bregman ra:
 

Daramic summary 

Email to Gilespie from Berger re:
 

Amendment
 

Email to Gilespie from Bregman re:
 

Amerace
 

Email to Bregman, Gilespie from
 

Shaw re: Daramic: Darak
 

Global Separator Strategy
 

Implementation Timeline TBG-


Americas
 

Email to Gilchrist from Ulsh re:
 

Exide/Microporous Supply 

Agreement 

DATE 

5/2/2007 

10/6/2006 

2/15/2007 

2/3/2007 

3/11/2008 

2/14/2008 

4/3/2007 

._-- 4/9/2008 

2/11/2008 

9/24/2007 

2/27/2008 

3/8/2006 

3/17/2006 

3/72008 

3/10/2008 

1/15/2007 

8/16/2005 

7/2/2005 

8/4/2005 

1/16/2008 

3/12/2006 

BEG DOC ENDDOC 

EX005900 EXOO6003 

EX005850 EX005850 -'-~--- . -­ EX002390 EXOO2451 

EX011938 EX011938 ._­

EX010588 EX010590


EXOOO027 EXOOO027 

EX001057 EXOO1059 

EX008649 EX008650 _..___.M_. ~ ......._..._..._-- - ---- --­

EXOOO057 EXOOO057 ~,~ ­

EX002380 EX002380 -

EX0033290 EX0033290 

EX024550 EX024551 

EX022213 EX022214 

EX011414 EX011415 

EX010718 EX010718 

EX011811 EX011812 

EX012123 EX012125 

ETI 0008324 ETI 0008324 

ETI 0007003 ETI 0007003
 -

ETIHC 0000058 ETfHC 0000059 

ETI 0019234 ETI 0019235 

CONFIDENTIAL - FTC DOCKET NO. 9327
 
---

---

- ----

---

COMPLAINT COUNSEL1S FINAL PROPOSED EXHIBIT LIST
 

EXHIBIT 

NO. 

PX1069 

PX1070 

PX1071 

PX1072 

PX1073 

PX1074 

PX1075 

PX1076 

PX1077 

PX1078 

PX1079 

PX1080 

PX1081 

PX1082 

PX1083 

PX1084 

PX1085 

PX1086 

PX1087 

PX1088 

."_w_ 

EXHIBIT TITLE 

Emaíl to Perez from McDonald re: 

Pricing w/Attach.
 

Emailto Gilespie from Bergman re:
 

Fol~?~-up
 -

Emailto Rombeiro, Gillespie, et al. 

from Brown re: Golf Cart Market 

Email to Gilespie from Brègman ra: 

Daramic Response to Industrial 

Profie w/Attach.
 

Emailto Gilespie, Menon, et a!. 

from Platz re: Thank you 

Email to Gillespie from Bregman re: 

Amerace 

Chart: Gè-Hb w/Amerace FlexSill.020 Glass Mat
 

Email to Perez from Bass re:
 

Pricing: Amerace V5. Daramic
 

w/Attach.
 

Letter to Gilespie from Roe re:
 

contract extension 

ChaI1:'PE Sër)~irators .. 

Email to Menon, Smith from piâfz 

re: Special Industrial Separators 

w/Altach. 

Non-Binding Memorandum of 

Understanding 

Amerace Agenda 

Email to Perez, Miller et al. from 

Graeme re: ENTEK International 

tooling quotation w/Attach. 

Email to Gilespie from Bregman re: 

Daramic 

Email to Berger from Miller re: 

Exide PE Separator Sample 

Request for European Product 

Weekly Report, Exide Technologies 

FY08 Purchasing Dashboard YTO 

Email to Perez from Miler re: 

Global Sap. Project - TBG - North 

America Status 

Email to McDonald from Perez re: 

Global Separator Conference in 

Paris 

Presentation: PE Separator 

Activites Transportation Americas 

-

-_. 

DATE BEGDOC ENDDOC 

2/19/2008	 EX008239 EX008246 - - . -­

4/26/2006 Ell 0006746 Ell 0006747
 ____. 

6/1/2006	 ETI 0006718 ETI 0006719 .-	 -_._--_.­

7/3/2006 Ell 0006695 Ell 0006696
 

7/10/2006 Ell 0019101 ETI 0019102
 -	 -._­

12/17/2006	 Ell 0007425 Ell 0007425
 

EX27511 EX27513
 ..	 .. 

EX009960 EX009968 .­

.....-......._- 6/1/2007	 EX002386 EX002389 ___H._____. ....__._------- -_._-_..._...., ......._-----­ EX009961 EX009968 ..­

7/6/2007	 EX023070 ,~.. EX023073 ..._-­

7/20/2007 EX006359 EX006365
 

2/27/2008 ETIHC 0000828 ETIHC 0000831
 

3/15/2008 EX010838 EX010839
 

7/21/2008 Ell 0006298 ETI 0006298
 

10/3/2007	 EllHC 0001190 EllHC 0001192 

10/22/2007 Ell 0005532 ETI 0005541 

12/13/2007 EX010100 EX010100 

1/212008 EX010452 EX010459 

1/10/2008 EX007054 EX007074 

CONFIDENTIAL - FTC DOCKET NO. 9327
 
--

EXHIBIT 

NO. 

PX1089 

PX1090 

PX1091 

PX1092 

PX1093 

PX1094 

PX1095 

PX1096 

PX1097 

PX1098 

PX1099 

PX1900 

PX1901 

PX1902 

COMPLAINT COUNSEL'S FINAL PROPOSED EXHIBIT LIST - .
 

EXHIBIT TITLE DATE BEGDOC ENDDOC 

Email to Menon from Smith re: 

Amersil 7/23/2008 ETI 0026243 ETI 0026243 - Chart: Global Separator Strategy
 

Implementation Timeline TBG-


Americas -.-1/16/2008 ETIHC 0000127 .~_. ETIHC 0000130 

Memo to Stephenson, Quintana, et
 

al. re: Global Separator Project
 

Update EX010483 EX010485 --- ___A ._. Email to Perez, Hoogestraat from
 

Berger re: Project Tracking Sheet
 

w/Atlach. 1/23/2008 EX010220 EX010233 

Email to Menon from Perez re:
 

Amerace Possible Locations
 

w/Atlach. - 1/24/2008 EX010601 EX010603 -.._-- Email to Perez from Graeme re: 

Global Separator Conference 

Action Items 1/25/2008 EX010855 EX010856 _. .- Email to Wimberly from Miler re: 

MPLP Material Characteristics 

w/Attach. --1/28/2008 - . 

EX005566 EX005566- Email to Berger from Miler re: 

Separator RFP: questions related to
 

US applications w/Attach. 1/29/2008 EX010018 EX010019
 _. --- . Email to McDonald from Perez re: 

Pricing - 2/5/2007 EX021597 EX021605 

Email to Perez from- Miler re:
 

Updated: Global Separator Strategy
 

Team Meeting 2/6/2008 ETIHC 0000120 ETIHC 0000120 

Email to Bregman from Gilespie re:
 

Answers to questions 7/24/2008 ETI 0005144 ETf 0005144
 

Email to Bruce, Bregman, et al.
 

from Gilespie ra: Exide Cost 

Documentation 10/24/2008 Elf 0005322 Ell 0005323 

Exida - Global Procurement 10/29/2008 Ell 0006605 ETI 0006635 

Email to Gilespie from Fraser-Bell 

ra: ENTEK International supply 

availabilty; 11/72008 Ell 0000009
 ETI 0000013

CONFIDENTIAL - FTC DOCKET NO. 9327
 
(f¿
 
PARKER POE
 

PAR POEADAMS & BERSTEIN LLP 

Eric D. Welsh Attorneys and Counselors at Law Three.Wachovia Center 

Partner 401 South Tryon Street 

Telephone: 704.335.9052 Suite 3000 

Direct Fax: 704.335.9755 Charlotte, NC 28202-1942 

ericwelshl!parkerpoe.com Telephone 704.372.9000 

Fax 704.334.4706 

March 27,2009 ww.parkerpoe.com 

VIA ELECTRONIC MAIL AND FIRST CLASS MAIL 

DONALD 1. RUSSELL, ESQ. 

Robbins, Russell, Englert, Orseck, Untereiner & Sauber 

1801 K Street, N.W. 

Washington, D.C. 20006 

drussell~robbinsrussel.com 

BARBARA A. HATCHER, Esq. 

Exide Technologies 

13000 Deerfield Parkway 

Building 200 

Alpharett, Georgia 30004 

barbara.hatcher~exide.com 

Re: In the Matter of Polypore International, Inc. 

Docket No. 9327 

Ladies and Gentlemen: 

My firm represents Polypore International, Inc. ("Polypore") in connection with a matter 

pending before the Federal Trade Commission entitled In the Matter of Polypore International, 

Inc., Docket No. 9327 (the "Matter"). The hearing of 
 this Matter Isset to begin on.May 12, 

2009. 

Pursuant to the terms of the Protective Order Governing Discovery Material 
 ("Protective Order")(a copy is enclosed) and Rule 3.45(b) of the Rules of Practice for Adjudicative
 

Proceedings before the UnìtedStates Federal Trade. Commission ("Rule3.45(b)"), you are hereby notified that Polypore' s . Counsel intends to. introduce 
 evidence containing Confidential 

Material, as that term is defined in the Protective Order, at the May 12, 2009. hearing of this Matter. The. Confidential Material may be in . 
 the form of documents Exide. has produced .to 

Polypore's Counsel, documents Exide has produced to the Federal Trade Commission, 

documents used in depositions of Ex ide witnesses, and/orthe deposition testimony or transcripts of Exide witnesses. 

The Confidential Material introduced 
 into .evidence.. at the hearing of this Matter wil 

continue to be subject to the Protective.Order, wmchsafeguardsagainst the Use or disclosure of

CHAESTON, SC
 

COLUMIA, SC
 

MYRTLE BEACH, SC 

RAEIGH, NC
 

SPARTANURG. SC
 

PPAB 1548903vl 
March 27, 2009 

Page 2
 

confidential information submitted or produced in connection with this Matter. However, please
 

be aware that all exhibits entered into evidence become par of the public record uness in
 

camera status is granted by Administrative Law Judge Chappell. Please let this letter serve as
 

formal notice that pursuant to the terms of the Protective 
 Order and Rule 3.45(b), you may obtain 

in camera treatment for such Confidential Material, or any portion thereof, only by appropriate 

motion to the Administrative Law Judge. If you have any questions regarding the foregoing, 

please feel.freeto contact me. 

Sincerely yours,
 

ç ~ tJ'£ /ßtt.
 

Eric D. Welsh 

EDW/brw 

Enclosure 

r 

i 

!" 

i 

I 

r 

I 

i 

I 

i 

, 

i 

I 

J

l 

I 

I 

i 

;

PPAB 1548903vl i

;
(18
 

J
 
B ,R FOE
 

PARIlPO¡¡ADAMS &BERNSTtLp 

Eric D. Welsh Attorneys and Counselors at L:w Three WachoviaCenter 

Partner 401 South Tryon Street 

Telephone: 704.335.9052 Suite 3000 

Direct Fax: 704.335.9755 Charlotte, NC 28202-1942 

ericwelsh((parkerpoe. com Telephone 704.372.9000 

Fax 704,334.4706 

March 31, 2009 www.parkerpoe.com 

VIA ELECTRONIC MAIL AND FIRST CLASS MAIL 

DONALD 1. RUSSELL, ESQ.
 

Robbins, Russell, Englert, Orseck, Untereiner & Sauber
 

1801 K Street, N.W.
 

Washington, D.C. 20006 

drusseii~robbinsrussel1.com 

BARBAR A. HATCHER, Esq. 

Exide Technologies
 

13000 Deerfield Parkway 

Building 200 

Alpharetta, Georgia 30004 

barbara.hatcher~exide.com 

Re: In the Matter of Polypore International, Inc. 

Docket No. 9327 

Ladies and Gentlemen: 

Following up on my letter of March 27, 2009, below please find a list identifying 

evidence Polypore International, Inc. ("Polypore") may introduce at the 
 May 12, 2009 hearing of 

the above-referenced matter. This list specifies the Exide documents on Polypore's trial exhibit 

list and the designation of testimony from Exide witness depositions. Please be advised 
 that 

pursuant to the terms of the Protective Order and..Rule 3.45(b), you may obtain in camera 

treatment for such . evidence, or any portion thereof, only by appropriate motion to the
 

Administrative Law Judge. If you have. any questions regarding the foregoing, please feel fre.e 

to contact me. 

Douglas Gilespie - p. 1, line 1 - p.3, line 19 

Deposition Date p. 7, line 2 - p. 8, line 3 

1/21/2009 p. 52, line!3 -po 53, line 2 

p. 54, line 6-p. 54, line 11 

p. 56, line 16 - p. 56, line 23 

p. 57, line 1 - p. 57, line 8
 

.57,line 12 ~ . 57,Jine 20
 

CHARESTON, SC
 

COLUMIA, SC
 

MYRTLE BEACH. SC 

RAEIGH, NC
 

SPARTANBURG, SC
 

PPAB 1549586vl 
March 31, 2009 

Page 2 

¡'-_:f'~~.;'2;;fjiF';"~,:æ~~~"-;,;_ ii -~ -;,::?!;,~;~1l'!iS~ " _,;,~~"":_ - ':.;_ "'_.
 . . ~ 1Jr)r~?!~_p~~~l~5Ir:~, v". ( ,".~ß:fL)~lf~1,l":~ '. ' \ ~£~~:til~~~~,~~~l~.. ' .:;:q~ ;¿L'? ~ ..~1 

p. 60, line 17 - p. 61, line 9
 

p. 66, line 1 - p. 66, line 12 

p. 66, line 23 - p. 67, line 25 

p. 68, line 20 - p.69, line 21 

p. 72, line 10 - p. 73, line 2
 

p. 83, line 13 - 22 

p. 88, line 6 - 16 

p. 95, line 8 - p. 95, line 21
 

p. 97, line 20 - p. 98, line 5
 

p. 98, line 24 - p. 99, line 5
 

p. 99, line 22 - p. 103, line 7
 

p. 104, line 9 - 21
 

p. 106, line 15 - p. 106, line 25
 

p. 109, line 21 - p. 114, line 13
 

p. 112, line 16 - p. 113, line 9
 

p. 113, line 12 - p. 114, line 13
 

p, 114, line 17 - 23 

p, 121, line 14-p. 121, line 19 

p. 122, line 3 - p. 122, line 20 

'p. 125, line 23 - p. 127, line 13
 

Douglas Gilespie - p. 145, line 1 - 25 

'Deposition Date p. 149,line9--p. 150, line 3

1/22/2009 p. 159, line 17 - p. 160, line 2 

p. 165, line 19 - p. 164, line 6
 

p. 169,Jine 14-p. 170,line23 

p. 171, line 20 - p. 172, line 7
 

p. 174, line 17 -: p. 177, line 5
 

p. 177, line 11 - p. 178, line 1
 

p. 189, line 11 - pi 191, line 8
 

p. 225, line 4 - p. 225, line 1 i 

Douglas Gilespie- p. 11, line 4 - 13 

Deposition Date p. 1 1, line 15 p~12;-lirre-1-6 

3/10/2009 p. 12, line 19 - p. 14, line 19 

p. 16, line 15 -18 

p. 16, line 22 - p. i 8, line 24 

p. 19, line 14 - p. 20, line 9
 

p. 25, line 17 - p. 27, line 15


~ "HI 'i;~~ ~ ~ "lQ I'ne 2' 4 -l" .f" 01
 

p. 30, line 19 - p. 32, line 11
 

p. 32, line 24 - p. 34, line 2 

p. 35, line 8 - p. 36, line 3
 

p. 37, line 8 - p. 38, line 24 

p. 39, line 5 - p. 40, line 16 

PPAB 1549586vl 
March 31, 2009 

Page 3
 

t;,~,,' ,tf(q!lXNìur";nl~~'i:~t~Rll~~:l~1'17~¿:.~:;~,~Q/;:??;;".t;M~i1.",."k~ ' .. ,~.Äli~:;~j;§J.iQ't~~l¥l~ )K~h,,:l~";"."'''~J~'r'? tfdi~~~#i-f '-. -,,, , : Jg~e, ; y\ ~v, "i'5 ' ,'mF~~e~!J'£-.:s~r l~':,,,l1:/ T '.::ú1; ,-7.. , , T ':i~~~§l~;;,;';im--/ :_,~, ,~;l!,-6,-~~,,~_ . "L,. ß:~' '. " I
 :t--t"~~ x" _;J~ ,___ , .. _ ;: ,?_;'~,' ~,. '_A _ ~:.d'~ ~~ ~',~ _ " , ~J;~~ ~,.,,, ,; \ X".. ,._-~~."¡ ""',i -~. 'i,', , " '
 

p. 42, line 2 - 10 

p. 43, line 3 - p. 44, line 14 

p. 44, line 18 - p. 46, line 7
 

p. 47, line 24 - p. 50, line 1
 

p. 51, line 20 - p. 52, line 23 

p. 53, line 6 - p. 54, line 22 

p. 55, line 5 - 16 

p. 57, line 1 - 15 

p. 57, line 19 - p. 58, line 6
 

p. 63, line 19 - p. 64, line 13
 

p. 64, line 1 1 - p. 66, line 20 

p. 67, line 13 - p. 70, line 16 

p. 71, line 6 - 12 

p. 73, line 9 - p. 74, line 1
 

p. 74, line 10 - 15
 

p, 74, line 25 - p. 75, line 14 

p. 75, line 23 - p. 78, line 11
 

p. 79, line 7 - p. 81, line 5
 

p. 81, line 14 - 16 

p. 83, line 2 - 14 

p. 85, line 22 - p. 86, line 5 

p. 86, line 22 - p, 87, line 8 

p. 88, line 2 - 11
 

p. 88, line 21 - p. 90, line 7 

p. 91, line 2 - 10 

p. 92, line 6 - 8 

p. 92, line 16 - p. 93, line 15
 

p. 93, line 25 - p. 95, line 8 

p. 98, line 17 - p. 99, line 1
 

p. 100, line 22 - p. 10 1, line 22
 

p. 104, line 24 - p, 105, line 7
 

p. 106, line 8 - p. 108, line 8
 

p. 109, line 11 - p. 112, line 13
 

p. 114, line 8 - 11
 

p. 116, line 8 - 11
 

p.117, line 3 - 10 

p. 118, line 4 - p. 119, line 13
 

p. 119, line 25 - p. 120, line 5
 

p. 120, line 25 - p. 121, line 17 

p. 123, line 22 - p. 125, line 18 

p. 125, line 22 - p. 127, line 5
 

p. 127, line 14 - 16 

p. 127, line 20 - 24 

130, line 7-p. 131,line6 

. 132, line 3 - . 134, line 25 

p. 

PP AB 1549586v I 
March 31, 2009
 

Page 4
 

."."~,' .,"",--!y-;.-;'-",';',;ì~¡_-""""'::' ;P;(t, ,"-'1,):':'"", 'J' '. '. ' ." '_¡¡'-".~? : ~ :: ~j3Ç~~ûu ,/!~)r~11(tV:.1ri~,~1 i ~,~ ~:~"''~:';:'f t, \ ;- ,,'" H li:~": !"))li~(~~'!tf';jt;f' ~ W:~~.;,,¥'!'"-;;i ,!.\
 .; ~."i~ ,:.."~ ~Y,' "'v. '"N=~¿' - , ;,"''l~~ ""," ~, , ..' ,.'#j:c~w_~ ?,~_ .,~ , -,
 

Pradeep Menon ­

Deposition Date 1/22/09
 

Alberto Perez ­

Deposition Date 

1/23/2009 

PPAB 1549586vl 

p. 135, line 6 - p. 137, line 5 

p. 138, line 15 - p. 139, line 25
 

p. 140, line 17 - 22 

p. 1, line 1 - 25 

p. 3, line 1 - 25 

p. 5, line 17 - p. 6, line 5
 

p. 6, line 21 - p. 7, line 16
 

p. 7, line 21 - p. 9, line 13
 

p. 14, line 14 - p. 15, line 3
 

p. 16, line 20 - 24 

p. 18,line5-p. 19line12
 

p. 20, line 10 -19 

p. 21, line 13 - 14
 

p. 24, line 14 - 19
 

p. 26, lines 3 - 6
 

p. 28, line 22 - p. 29, line 21
 

p. 36, lines 8 - 21
 

p. 39, lines 8 - 11
 

p, 40, lines 10 - 15
 

p. 40, line 21 - p. 41 line 7 

p. 55, lines 15 - 20
 

p. 56, lines 3 - 13
 

p~ 63, line 14 - p. 64, line 10
 

p. 66,lineI8-p. 67,line3
 

p. 81, line 17 - p. 82, line 11
 

p. 84, lines 16 - 23
 

p. 85, line 17 - p. 86, line 14
 

p. 87, line 25 - p. 88, line 18
 

p. 93, line 19 - p. 94, line 3
 

p. 95, line 20 - p. 97, line 2
 

p. 98, lines 1 - 5
 

p. 98, lines 16 - 18
 

p. 101, lines 4 - 20
 

p. 103, line 20 - p. 104 line 9 

p. 105, lines 10-17 

p. 110, line 18 - p. 111, line 24
 

p. 113, lines 5 - 15
 

p. 1, line 1 - p. 3, line 12 

p. 52, line 13 - p. 53, line 2
 

p. 54, line 6 - p. 54, line 11
 

p. 57, line 1 - p. 57, line 8 

p. 66, line 1 - p. 66, line 12
 

p. 66, line 23 - pi 67, line 25 

p. 68, line 20 - p. 69, line 21
 
March 31, 2009 

Page 5
 

~_.3':-æt ~;:'''MlI~''~~~0r~lI~''bi !""- ::::':;:~:~ ~.,-".'l,h, ~'M:.~' ~ "$ ", 'v ,;';\ i "¡; ",."ž -lLl.~;,.y~",::"-2r'.ß


~ ."'?i ngfDr01¡;;C-!f(tJól1jzj~lE' ~æ ~if:~f~¡.'-~~~~~ 'G.J~~~:w;~-:Jt, r il~ ' ¿i~~l;"" ",/, /'LI),"';~~¡,n))9¿~l:~,;k~..¡,i~1~(": /' ~ ,~ P:Y~~ '_' -~::;j

- ""," v" '1~ " " . '- :.~ ,'- ¡;' ',-,\~' _'~ ~~,r¡.~53t~.,l' O'\\.~ ¿.~'",=! , _ _ _ _ "~ __ _ l ,,~ ~~""'" ~".., ",1
 -

p. 112, line 16 - p. 113, line 9
 

p. 113, line 13 - p. 114, line 13
 

p. 121, line 14 - p. 121, line 19
 

p. 122, line 3 - p. 122, line 20 

Gordon Ulsh- p. 8, line 20 - p. 9, line 10 

Deposition Date p. 12, line 4 -' p. 13, line 3 

1/21/2009 p. 13, line 21 - p. 14, line 11 

p. 18, line 14 - p. 19, line 12
 

p. 20, line 20 - p. 22, line 21 

p. 23, line 13 - p. 24, line 9
 

p. 27, line 16 - p. 28, line 8
 

p. 30, line 17 - p. 31, line 2
 

p. 32, lines 8 - 13 

p. 42, line 7 - p. 47, line 23 

p. 48, line 21 - p. 50, line 3
 

p. 50, line 5 - p. 55, line 21
 

p. 61, line 8 - 25 

p. 64, line 3 - p. 65, line 22 

p. 67; line 9 - p. 68, line 4
 

p. 68, line 15 - 23 

p. 82, line 23 - p. 83, line 18
 

p. 85, line 14 - p. 87, line 3
 

p. 92, line 6 - p. 99, line 4
 

p. 105, line 4 - p. 110, line 18
 

p. 112, line 6 - p. 114, line 23
 

p. 115, line 8 - p. 118, line 6
 

p. 124, line 1 - p. 126, line 12
 

p. 126, line 21 - p. 129, line 5
 

p. 138, line 9 - 19 

Douglas Gilespie - Entire Transcript 

Investigational Hearing 

Date 5/8/2008
 

Trial Ex. Description Date Begin Doc. No. End Doc. No. 

No. 

RXOOO02 Email from Bell re: 11/07/08 ETI 0000009 ETI _0000013 

Entek Supply 

availability 

RXOOO06 E-mail string Re 1 1/03/08 En 0000018 En _0000018 

Separator Inventorv 

RXOOO 1 4 Email re: Supply 06/22/07 En 0000267 En 0000277 

from EuroDe 

PPAB 1549586vl 
March 31, 2009 

Page 6
 

RX00305	 PE Separator 

Supplier Info
 

RXOOO 16 Email re: Samples of 

Special Separators 

RX00308 Email from Gilespie 

re: Answers to 

questions 

RX00304 Battery Separator 

Supplier List 

RX00318 Global Separator 

Conference 

RX00314 Amerace Executive 

Overview 

RX00317 Email from Bregman 

re: Letter to Daramic 

RX003 1 1	 Email from Menon 

re: Industrial Project 

Review Meeting 

RX00319	 Email from Bregman 

re: Exide Cost 

Documentation 

RX00302	 Emaol from 

Gonzalez re: Exide 

Industrialplex 

RX00303 PE Separator 

Strategy 

RX00320 Engineering Work 

Request 

RX00309 Market Overview 

RX00324 Email from Gilespie 

re: Golf Car 

Separator 

Availability 

RX00312	 Email from Gilespie 

re: Nippon Sheet 

Glass AGM 

Separator 

RX00306 Supplier Profie 

RX00307 Supplier Profie 

RX00310 Email from Perez re: 

Entek tooling
 

quotation 

RX00300 Global Separators 

Strategy Outlook 

00/00/00 

08/16/08 

07/24/08 

00/00/00 

01/00/07 

03/14/06 

02/08/07 

10/22/08 

11/02/08 

05/09/08 

07/1 0/08 

06/28/06 

10/29/08 

10/10/08 

08/13/08 

10/22/07 

10/25/07 

03/15/08 

02/27/08 

ETI 0001965 ETI 0001965 

ETI 0002765 ETI 0002766 

ETI 0005144 ETI 0005144 

ETI 0005149/1 ETI 0005149/4 

ETI 0005743 ETI 0005746 

ETI 0006173 ETI 0006177 

ETI 0006548 ETI 0006548 

ETI 0006640 ETI 0006641 

ETI 0006671 ETI 0006672 

ETI 0017868 ETI 0017869 

ETI 0019983 ETI 0019990 

ETI 0036479 ETI 0036483 

ETI 0040844 ETI 0040847 

ETI 0043458 ETI 0043461 

ETI 0044036 ETI 0044036 

ETI 0057658 ETI 0057662 

ETI 0057663 ETI 0057667 

ETI 0058576 ETI 0058577 

ETI_ 0059088 ETI 0059098 

PP AB i 549586v 1 
March 31, 2009 

Page 7
 

RX00301 Global Procurement 

FY09 Plan 

RX00315 Exide Supplier 

Excellence Program 

RX00316	 Email from Miler re: 

Exide PE Separator 

Sample Request for 

European Product 

RX00322	 Engineering Wark 

Request . 

RX003 1 3	 Nort America Sales 

Outlook 

Opportunties & 

Curent Projects 

RX00321	 Engineering Work 

Request 

RX00323	 Exide Highlights 

RX00359	 Email from Kathie 

Perzee 

RXOO020 Email re: High Cyder 

Separator 

RXOOO03 Emails re: Serrated 

Separator 

RX0036.0 Email from Berger to 

Perèz 

RX00263 Email McDonald to 

Perez re Pricing 

RX00264	 Email Simon to Perez 

RX00265	 EmaIl Mennon to 

Simon Contract for 

supplies 

RX00266 Email Miler to Perez 

re Entek 

RX00267 Email Miler to Perez 

re Entek 

RX00268	 Email Berger to 

Perez 

RX00269	 Letter to Gilespie re 

Global Supply 

Contract 

RXOOO09	 E-mail string re Roll 

Separator 

RXOOOl1	 Amerace Agenda 

RXOOO 17	 Nort American 

Supply Agreement 

00/00/09 

0'0/00/00 

1 % 1/07 

11/28/07 

10/07/08 

04/14/08 

01/04/08 

1 1/03/08 

09/25/08 

02/21/08 

02/21/08 

02/06/08 

02/25/08 

12/20/07 

12/1 1/07 

12/11/07 

02/26/08 

12/21/07 

02/18/08 . 

02/27/08 

12/15/99 

ETI 0059099 ETI 0059106 

ETI 0059128 ETI 0059142 

ETI 0063244 ETI 0063246 

ETI 0072382 ETI 0072389 

ETI 0073695 ETI 0073734 

ETI 0080262 ETI 0080263 

ETI 0081738 ETI 0081746 

ETI -0000018 ETI 0000018 

ETIOOO4208 ETI0004210 

ETIHC 0000004 ETIHC 0000005 

ETIHC _0000004 ETIHC 0000009 

ETIHC 0000010 ETIHC 0000016 

ETIHC 0000017 ETIHC 0000041 

ETIHC 0000042 ETIHC 0000047 

ETIHC 0000048 ETIHC 0000048 

ETIHC 0000050 ETrnC 0000054 

ETIHC _0000055 ETIHC_ 0000069 

ETIHC 0000070 ETIHC 0000078 

ETIHC _ 0000079 ETIHC 0000081 

ETIHC 0000828 ETIHC 0000830 

ETIHC 0001712 ETIHC 0001758 

PPAB 1549586vl 
March 31, 2009 

Page 8
 

RXOO015 Email re: Pricing
 

RXOOO12 Daramic Curent
 

Situation
 

RX00361	 Email Bregman to
 

Gillespie re Tudor
 

India
 

RXOOO 19 Email re: Supporting 

Documentation 

RXOOO08 E-mail, Weerts to 

Menon 

RXOOO 13	 Global Poly 

Separator RFQ 

Techncal 

Requirements 

RX00145	 Email from Weerts 

re: Separator RFP 

RX00362	 Global Poly 

Separator RFP 

Commercial 

Requirements 

RX00144	 Letter from Menon 

re: Exide RFP for 

Global separator 

RXOOO 10 E-mail string re 

MOU 

RXOOO04 Email re: Global Sep. 

Project 

RXOOO07	 E-mail string re 

Global Conference 

Notes 

RXOOO 18	 Email re: Possible 

Chinese Separator 

Suppliers 

RXOOOO 1	 Emails re: Global 

Separator Conference 

Action Items 

RXOOIlO Email re Euroe and 

India Agreements 

RXOOO05 Subpoena Ad 

Testificandum to 

Exide Technologies 

RXO 1186	 Exide Form 10- K 

RX00899	 Letter from Diasio to 

Nasisi re: Corydon 

02/05/08 

00/00/00 

07/27/05 

04/08/08 

03/24/08 

04/30/07 

06/15/07 

00/00/00 

06/00/07 

02/14/08 

12/13/07 

01/16/08 

02/25/08 

01/25/08 

04/16/08 

12/10/08 

Filed 6/09/08 

12/16/98 

EX 021597 

EXOO0269 

EXOO0774 

EXOO1075 

EX00250 1 

EX002532 

EX003662 

EX004405 

EX004554 

EX009775 

EXO 10 100 

EXOI0166 

EX010363 

EX010855 

EXOI1386 

WACHÆXIDE1235 

EX021605 

EXOO0269 

EX001108 

EX001083 

EX002501 

EX002544 

EX003677 

EX004406 

ENTEK 004535 

EX009776 

EXO 10 1 00 

EXOI0167 

EXOI0364 

EXOI0856 

EX011388 

W ACHÆXIDE1239
 

PPAB 1549586vl 
March 31, 2009 

Page 9 

Facilty 

RX01505 FaxtoJ. Kenney 04/01/199 WACH/XIDE2241 W ACH/EXIDE2243 

from v. 

Hol1ngsworth 

Sincerely yours, 

l(.. LJ J. I r¿ ¡z w
 

Eric D. Welsh 

EDW/brw 

PPAB 1549586vl